Ross\Johnson & Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$164 269
2025
Q4
$164 Buy
+2
New +$156 ﹤0.01% 267
2025
Q2
Sell
-6
Closed -$484 266
2025
Q1
$484 Hold
6
0.01% 248
2024
Q4
$469 Buy
+6
New +$510 0.01% 87

Other funds holding GEHC

Ross\Johnson & Associates's GEHC Position: Q1 2026 in Review

Ross\Johnson & Associates sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 2 shares — an estimated $164 sold.

Ross\Johnson & Associates first reported a position in GEHC in Q4 2024 and held it in 3 quarters. The position peaked at $484 in Q1 2025. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Ross\Johnson & Associates reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Ross\Johnson & Associates sold 2 GE HealthCare shares in Q1 2026, an estimated $164.
  • Ross\Johnson & Associates first reported a position in GE HealthCare in Q4 2024 and held it in 3 quarters.
  • Ross\Johnson & Associates's GE HealthCare position peaked at $484 in Q1 2025.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.